메뉴 건너뛰기




Volumn 66, Issue 4, 1998, Pages 1547-1553

Bivalency Is Required for Anticapsular Monoclonal Antibodies to Optimally Suppress Activation of the Alternative Complement Pathway by the Cryptococcus neoformans Capsule

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; FUNGUS ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

EID: 0032038839     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.4.1547-1553.1998     Document Type: Article
Times cited : (10)

References (38)
  • 1
    • 0031034049 scopus 로고    scopus 로고
    • Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay
    • Belay, T., R. Cherniak, T. R. Kozel, and A. Casadevall. 1997. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect. Immun. 65:718-728.
    • (1997) Infect. Immun. , vol.65 , pp. 718-728
    • Belay, T.1    Cherniak, R.2    Kozel, T.R.3    Casadevall, A.4
  • 2
    • 0028122571 scopus 로고
    • Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan
    • Casadevall, A., M. DeShaw, M. Fan, F. Dromer, T. R. Kozel, and L. Pirofski. 1994. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:3864-3872.
    • (1994) Infect. Immun. , vol.62 , pp. 3864-3872
    • Casadevall, A.1    DeShaw, M.2    Fan, M.3    Dromer, F.4    Kozel, T.R.5    Pirofski, L.6
  • 3
    • 0026568749 scopus 로고
    • Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection
    • Casadevall, A., J. Mukherjee, S. J. N. Devi, R. Schneerson, J. B. Robbins, and M. D. Scharff. 1992. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 165:1086-1093.
    • (1992) J. Infect. Dis. , vol.165 , pp. 1086-1093
    • Casadevall, A.1    Mukherjee, J.2    Devi, S.J.N.3    Schneerson, R.4    Robbins, J.B.5    Scharff, M.D.6
  • 4
    • 0028018918 scopus 로고
    • Serum therapy revisited: Animal models of infection and development of passive antibody therapy
    • Casadevall, A., and M. D. Scharff. 1994. Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1695-1702.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 1695-1702
    • Casadevall, A.1    Scharff, M.D.2
  • 5
    • 3543069883 scopus 로고
    • Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies
    • Dangl, J. L., T. G. Wensel, S. L. Morrison, L. Stryer, L. A. Herzenberg, and V. T. Oi. 1988. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7:1989-1994.
    • (1988) EMBO J. , vol.7 , pp. 1989-1994
    • Dangl, J.L.1    Wensel, T.G.2    Morrison, S.L.3    Stryer, L.4    Herzenberg, L.A.5    Oi, V.T.6
  • 6
    • 0030174340 scopus 로고    scopus 로고
    • Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model
    • Devi, S. J. 1996. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model. Vaccine 14:841-844.
    • (1996) Vaccine , vol.14 , pp. 841-844
    • Devi, S.J.1
  • 7
    • 0026005115 scopus 로고
    • Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: Synthesis, characterization, and immunogenicity
    • Devi, S. J. N., R. Schneerson, W. Egan, T. J. Ulrich, D. Bryla, J. B. Robbins, and J. E. Bennett. 1991. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect. Immun. 59:3700-3707.
    • (1991) Infect. Immun. , vol.59 , pp. 3700-3707
    • Devi, S.J.N.1    Schneerson, R.2    Egan, W.3    Ulrich, T.J.4    Bryla, D.5    Robbins, J.B.6    Bennett, J.E.7
  • 8
    • 0016218583 scopus 로고
    • The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection
    • Diamond, R. D., J. E. May, M. A. Kane, M. M. Frank, and J. E. Bennett. 1974. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J. Immunol. 112:2260-2270.
    • (1974) J. Immunol. , vol.112 , pp. 2260-2270
    • Diamond, R.D.1    May, J.E.2    Kane, M.A.3    Frank, M.M.4    Bennett, J.E.5
  • 9
    • 0023141305 scopus 로고
    • Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody
    • Dromer, F., J. Charreire, A. Contrepois, C. Carbon, and P. Yeni. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752.
    • (1987) Infect. Immun. , vol.55 , pp. 749-752
    • Dromer, F.1    Charreire, J.2    Contrepois, A.3    Carbon, C.4    Yeni, P.5
  • 10
    • 0023395442 scopus 로고
    • Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide
    • Eckert, T. F., and T. R. Kozel. 1987. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:1895-1899.
    • (1987) Infect. Immun. , vol.55 , pp. 1895-1899
    • Eckert, T.F.1    Kozel, T.R.2
  • 11
    • 0011188401 scopus 로고
    • Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms
    • Fearon, D. T., and K. F. Austen. 1977. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. Proc. Natl. Acad. Sci. USA 74:1683-1687.
    • (1977) Proc. Natl. Acad. Sci. USA , vol.74 , pp. 1683-1687
    • Fearon, D.T.1    Austen, K.F.2
  • 13
    • 0017874586 scopus 로고
    • Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
    • Fraker, P. J., and J. C. Speck, Jr. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849-857.
    • (1978) Biochem. Biophys. Res. Commun. , vol.80 , pp. 849-857
    • Fraker, P.J.1    Speck Jr., J.C.2
  • 14
    • 0021905252 scopus 로고
    • Species specificity of recognition by the alternative pathway of complement
    • Horstmann, R. D., M. K. Pangburn, and H. J. Müller-Eberhard. 1985. Species specificity of recognition by the alternative pathway of complement. J. Immunol. 134:1101-1104.
    • (1985) J. Immunol. , vol.134 , pp. 1101-1104
    • Horstmann, R.D.1    Pangburn, M.K.2    Müller-Eberhard, H.J.3
  • 15
    • 0018317786 scopus 로고
    • Human alternative complement pathway: Membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b
    • Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122:75-81.
    • (1979) J. Immunol. , vol.122 , pp. 75-81
    • Kazatchkine, M.D.1    Fearon, D.T.2    Austen, K.F.3
  • 16
    • 0030029567 scopus 로고    scopus 로고
    • Activation of the complement system by pathogenic fungi
    • Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9:34-46.
    • (1996) Clin. Microbiol. Rev. , vol.9 , pp. 34-46
    • Kozel, T.R.1
  • 17
    • 0032038623 scopus 로고    scopus 로고
    • Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule
    • Kozel, T. R., B. C. H. deJong, M. M. Grinsell, R. S. MacGill, and K. K. Wall. 1998. Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule. Infect. Immun. 66:1538-1546.
    • (1998) Infect. Immun. , vol.66 , pp. 1538-1546
    • Kozel, T.R.1    DeJong, B.C.H.2    Grinsell, M.M.3    MacGill, R.S.4    Wall, K.K.5
  • 18
    • 0022620944 scopus 로고
    • Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
    • Kozel, T. R., and G. S. T. Pfrommer. 1986. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect. Immun. 52:1-5.
    • (1986) Infect. Immun. , vol.52 , pp. 1-5
    • Kozel, T.R.1    Pfrommer, G.S.T.2
  • 19
    • 0023815541 scopus 로고
    • Strain variation in phagocytosis of Cryptococcus neoformans: Dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3
    • Kozel, T. R., G. S. T. Pfrommer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect. Immun. 56:2794-2800.
    • (1988) Infect. Immun. , vol.56 , pp. 2794-2800
    • Kozel, T.R.1    Pfrommer, G.S.T.2    Guerlain, A.S.3    Highison, B.A.4    Highison, G.J.5
  • 20
    • 0025784562 scopus 로고
    • Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans
    • Kozel, T. R., M. A. Wilson, and J. W. Murphy. 1991. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect. Immun. 59:3101-3110.
    • (1991) Infect. Immun. , vol.59 , pp. 3101-3110
    • Kozel, T.R.1    Wilson, M.A.2    Murphy, J.W.3
  • 21
    • 0024355263 scopus 로고
    • Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins
    • Kozel, T. R., M. A. Wilson, G. S. T. Pfrommer, and A. M. Schlageter. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
    • (1989) Infect. Immun. , vol.57 , pp. 1922-1927
    • Kozel, T.R.1    Wilson, M.A.2    Pfrommer, G.S.T.3    Schlageter, A.M.4
  • 22
    • 0028938643 scopus 로고
    • Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell
    • Mukherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell. J. Exp. Med. 181:405-409.
    • (1995) J. Exp. Med. , vol.181 , pp. 405-409
    • Mukherjee, J.1    Nussbaum, G.2    Scharff, M.D.3    Casadevall, A.4
  • 23
    • 0027466445 scopus 로고
    • Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection
    • Mukherjee, J., L. Pirofski, M. D. Scharff, and A. Casadevall. 1993. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA 90:3636-3640.
    • (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 3636-3640
    • Mukherjee, J.1    Pirofski, L.2    Scharff, M.D.3    Casadevall, A.4
  • 24
    • 0026495128 scopus 로고
    • Protective murine monoclonal antibodies to Cryptococcus neoformans
    • Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
    • (1992) Infect. Immun. , vol.60 , pp. 4534-4541
    • Mukherjee, J.1    Scharff, M.D.2    Casadevall, A.3
  • 25
    • 0031035947 scopus 로고    scopus 로고
    • Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy
    • Nussbaum, G., W. Cleare, A. Casadevall, M. D. Scharff, and P. Valadon. 1997. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J. Exp. Med. 185:685-695.
    • (1997) J. Exp. Med. , vol.185 , pp. 685-695
    • Nussbaum, G.1    Cleare, W.2    Casadevall, A.3    Scharff, M.D.4    Valadon, P.5
  • 26
    • 0021277712 scopus 로고
    • Correlation between segmental flexibility and effector function of antibodies
    • Oi, V. T., T. M. Vuong, R. Hardy, J. Reidler, J. Dangl, L. A. Herzenberg, and L. Stryer. 1984. Correlation between segmental flexibility and effector function of antibodies. Nature 307:136-140.
    • (1984) Nature , vol.307 , pp. 136-140
    • Oi, V.T.1    Vuong, T.M.2    Hardy, R.3    Reidler, J.4    Dangl, J.5    Herzenberg, L.A.6    Stryer, L.7
  • 27
    • 0011579669 scopus 로고
    • Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells
    • Pangburn, M. K., and H. J. Müller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75:2416-2420.
    • (1978) Proc. Natl. Acad. Sci. USA , vol.75 , pp. 2416-2420
    • Pangburn, M.K.1    Müller-Eberhard, H.J.2
  • 28
    • 0016219289 scopus 로고
    • Activation of the alternative pathway of human complement by rabbit cells
    • Platts-Mills, T. A. E., and K. Ishizaka. 1974. Activation of the alternative pathway of human complement by rabbit cells. J. Immunol. 113:348-357.
    • (1974) J. Immunol. , vol.113 , pp. 348-357
    • Platts-Mills, T.A.E.1    Ishizaka, K.2
  • 29
    • 0028124668 scopus 로고
    • Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation
    • Sahu, A., T. R. Kozel, and M. K. Pangburn. 1994. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. Biochem. J. 302:429-436.
    • (1994) Biochem. J. , vol.302 , pp. 429-436
    • Sahu, A.1    Kozel, T.R.2    Pangburn, M.K.3
  • 30
    • 0025309182 scopus 로고
    • Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide
    • Sanford, J. E., D. M. Lupan, A. M. Schlageter, and T. R. Kozel. 1990. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect. Immun. 58:1919-1923.
    • (1990) Infect. Immun. , vol.58 , pp. 1919-1923
    • Sanford, J.E.1    Lupan, D.M.2    Schlageter, A.M.3    Kozel, T.R.4
  • 32
    • 84969001783 scopus 로고
    • The attractions of proteins for small molecules and ions
    • Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:660-672.
    • (1949) Ann. N. Y. Acad. Sci. , vol.51 , pp. 660-672
    • Scatchard, G.1
  • 33
    • 0025279526 scopus 로고
    • Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide
    • Schlageter, A. M., and T. R. Kozel. 1990. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect. Immun. 58:1914-1918.
    • (1990) Infect. Immun. , vol.58 , pp. 1914-1918
    • Schlageter, A.M.1    Kozel, T.R.2
  • 34
    • 0019379107 scopus 로고
    • The covalent-binding reaction of complement component C3
    • Sim, R. B., T. M. Twose, D. S. Paterson, and E. Sim. 1981. The covalent-binding reaction of complement component C3. Biochem. J. 193:115-127.
    • (1981) Biochem. J. , vol.193 , pp. 115-127
    • Sim, R.B.1    Twose, T.M.2    Paterson, D.S.3    Sim, E.4
  • 35
    • 0024459776 scopus 로고
    • Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide
    • Spiropulu, C., R. A. Eppard, E. Otteson, and T. R. Kozel. 1989. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide. Infect. Immun. 57: 3240-3242.
    • (1989) Infect. Immun. , vol.57 , pp. 3240-3242
    • Spiropulu, C.1    Eppard, R.A.2    Otteson, E.3    Kozel, T.R.4
  • 36
    • 77957054855 scopus 로고
    • The third, fourth, and fifth components of human complement: Isolation and biochemical properties
    • Tack, B. F., J. Janatova, M. L. Thomas, R. A. Harrison, and C. H. Hammer. 1981. The third, fourth, and fifth components of human complement: isolation and biochemical properties. Methods Enzymol. 80:64-101.
    • (1981) Methods Enzymol. , vol.80 , pp. 64-101
    • Tack, B.F.1    Janatova, J.2    Thomas, M.L.3    Harrison, R.A.4    Hammer, C.H.5
  • 37
    • 0026520198 scopus 로고
    • Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans
    • Wilson, M. A., and T. R. Kozel. 1992. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 60:754-761.
    • (1992) Infect. Immun. , vol.60 , pp. 754-761
    • Wilson, M.A.1    Kozel, T.R.2
  • 38
    • 0027200210 scopus 로고
    • Effects of strain variation, serotype and structural modification on the kinetics for activation and binding of C3 to Cryptococcus neoformans
    • Young, B. J., and T. R. Kozel. 1993. Effects of strain variation, serotype and structural modification on the kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 61:2966-2972.
    • (1993) Infect. Immun. , vol.61 , pp. 2966-2972
    • Young, B.J.1    Kozel, T.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.